Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT00818259
Eligibility Criteria:
Inclusion Criteria:
* Is 0 (at least 37 weeks gestation) to 17 years of age
* Is scheduled to receive moderately to highly nausea-inducing chemotherapy or participant did not tolerate a previous chemotherapy regimen that is planned to be repeated
* Is expected to receive ondansetron
* Female participants who have begun menstruating must have a negative pregnancy test
* Weighs ≥3.0 kg if \<6 months of age, ≥6.0 kg if \>6 months of age, and ≥7.5 kg if \> 2 years of age
* Has a pre-existing venous catheter
Exclusion Criteria:
* Uses any illicit drugs or abuses alcohol
* Is pregnant or breast feeding
* Has a symptomatic central nervous system (CNS) tumor
* Has an infection or other uncontrolled disease other than cancer
* Has known history of heart QT wave prolongation
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00818259
Study Brief:
Protocol Section:
NCT00818259